The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas

Human Pathology

Volumn 44, Issue 12, 2013, Pages 2651-2657

  Gonzalez Roibon, Nilda ^a,c   Albadine, Roula ^a,d   Sharma, Rajni ^a   Faraj, Sheila F ^a   Illei, Peter B ^a   Argani, Pedram ^a   Ertoy, Dilek ^b   Allaf, Mohamad E ^a   Netto, George J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Collecting duct carcinoma; GATA3; Upper tract urothelial carcinoma

Indexed keywords

PROTEIN P63; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PAX8;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLECTING DUCT CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; PREDICTIVE VALUE; PROTEIN EXPRESSION; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA;

COLLECTING DUCT CARCINOMA; GATA3; UPPER TRACT UROTHELIAL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PAIRED BOX TRANSCRIPTION FACTORS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84888068230     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.07.006     Document Type: Article

References (28)

1. A.J. Wein, L.R. Kavoussi, A.C. Novick, A.W. Partin, and C.A. Peters Campbell-Walsh urology 2012 Saunders Philadelphia
2. H. Kafe, J.M. Verbavatz, B. Cochand-Priollet, P. Castagnet, and A. Vieillefond Collecting duct carcinoma: an entity to be redefined? Virchows Arch 445 2004 637 640
3. N. Kobayashi, O. Matsuzaki, S. Shirai, I. Aoki, M. Yao, and Y. Nagashima Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis Hum Pathol 39 2008 1350 1359
4. R. Albadine, L. Schultz, and P. Illei PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract Am J Surg Pathol 34 2010 965 969
5. J.C. Carvalho, D.G. Thomas, J.B. McHugh, R.B. Shah, and L.P. Kunju p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system Histopathology 60 2012 597 608
6. R. Gupta, B. Balzer, and M. Picken Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms Am J Surg Pathol 33 2009 241 247
7. S. Gunia, A. Erbersdobler, and S. Koch Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis Hum Pathol 44 2013 712 717
8. I.C. Ho, P. Vorhees, and N. Marin Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene EMBO J 10 1991 1187 1192
9. L.J. Ko, M. Yamamoto, M.W. Leonard, K.M. George, P. Ting, and J.D. Engel Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer Mol Cell Biol 11 1991 2778 2784
10. R. Zheng, and G.A. Blobel GATA transcription factors and cancer Genes Cancer 1 2010 1178 1188
11. M.L. Asselin-Labat, K.D. Sutherland, and H. Barker Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 2007 201 209
12. H. Kouros-Mehr, E.M. Slorach, M.D. Sternlicht, and Z. Werb GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland Cell 127 2006 1041 1055
13. J. Chou, S. Provot, and Z. Werb GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 222 2010 42 49
14. M. Yang, and D. Nonaka A study of immunohistochemical differential expression in pulmonary and mammary carcinomas Mod Pathol 23 2010 654 661
15. H. Van Esch, P. Groenen, and M.A. Nesbit GATA3 haplo-insufficiency causes human HDR syndrome Nature 406 2000 419 422
16. J.P. Higgins, G. Kaygusuz, and L. Wang Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680
17. G.E. Esheba, T.A. Longacre, K.A. Atkins, and J.P. Higgins Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations Am J Surg Pathol 33 2009 347 353
18. H. Liu, J. Shi, M.L. Wilkerson, and F. Lin Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas Am J Clin Pathol 138 2012 57 64
19. J.N. Eble, G. Sauter, J.I. Epstein, and I.A. Sesterhenn World Health Organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs 2004 IARC Press Lyon, France
20. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
21. A. Orsola, I. Trias, C.X. Raventos, I. Espanol, L. Cecchini, and I. Orsola Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma Urology 65 2005 49 54
22. J.R. Srigley, and J.N. Eble Collecting duct carcinoma of kidney Semin Diagn Pathol 15 1998 54 67
23. J.R. Srigley, and B. Delahunt Uncommon and recently described renal carcinomas Mod Pathol 22 2009 2 23
24. A. Chang, A. Amin, and E. Gabrielson Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung Am J Surg Pathol 36 2012 1472 1476
25. H. Miyamoto, K. Izumi, and J.L. Yao GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor Hum Pathol 43 2012 2033 2040
26. G.X. Tong, W.M. Yu, and N.T. Beaubier Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study Mod Pathol 22 2009 1218 1227
27. C. Langner, M. Ratschek, O. Tsybrovskyy, L. Schips, and R. Zigeuner P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors J Histochem Cytochem 51 2003 1097 1099
28. N. Janzen, A. Zisman, A.J. Pantuck, K. Perry, P. Schulam, and A.S. Belldegrun Minimally invasive ablative approaches in the treatment of renal cell carcinoma Curr Urol Rep 3 2002 13 20